Align Technology PE Ratio 2006-2018 | ALGN

Current and historical price to earnings ratio for Align Technology (ALGN) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Align Technology PE ratio as of September 21, 2018 is 81.55.
Align Technology Annual PE Ratio
Align Technology Quarterly PE Ratio
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $30.589B $1.473B
Align Technology, Inc. is a global medical device company with industry-leading innovative products such as Invisalign clear aligners, iTero Intraoral scanners, and OrthoCAD digital services that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.973B 25.05
McKesson (MCK) United States $26.959B 10.32
AmerisourceBergen (ABC) United States $19.500B 14.17
Laboratory Of America Holdings (LH) United States $17.535B 16.13
Cardinal Health (CAH) United States $16.967B 11.45
Cooper (COO) United States $13.215B 23.80
Henry Schein (HSIC) United States $13.117B 22.37
West Pharmaceutical Services (WST) United States $8.942B 46.23
DENTSPLY SIRONA (XRAY) United States $8.618B 15.08
Merit Medical Systems (MMSI) United States $3.361B 44.17
Patterson (PDCO) United States $2.435B 17.11
CONMED (CNMD) United States $2.190B 37.10
STAAR Surgical (STAA) United States $2.063B 276.18
Atrion (ATRI) United States $1.219B 36.13
Antares Pharma (ATRS) United States $0.513B 0.00
Invacare (IVC) United States $0.490B 0.00
Lifevantage (LFVN) United States $0.168B 23.86
Endologix (ELGX) United States $0.152B 0.00
Aceto (ACET) United States $0.094B 3.80
Pro-Dex (PDEX) United States $0.055B 24.33
Biolase (BIOL) United States $0.045B 0.00